Condition

Diabetic Neuropathic Pain

ClinicalTrials.gov condition label

Clinical trials5

Recruiting0

Common interventions11

Lead sponsors shown5

Clinical trials

5 shown

the Effectiveness of Intermittent Pneumatic Compression on Neuropathic Pain in Patients With Diabetic PolyneuropathyNCT06336486 · 2018-12-04

COMPLETED

A Multicenter Study Comparing the Analgesic Effects and Safety of ABT-639 Compared to Placebo in Subjects With Diabetic Neuropathic PainNCT01345045 · 2011-04-01

COMPLETED

Three Way Interaction Between Gabapentin, Duloxetine, and Donepezil in Patients With Diabetic NeuropathyNCT00619983 · 2008-02-01

TERMINATED

Efficacy and Tolerability of Novel A2A Agonist in Treatment of Diabetic Neuropathic PainNCT00452777 · 2007-05-01

COMPLETED

Genetics of Diabetes Audit and Research in Tayside Scotland (DOLORisk Dundee)NCT02783469 · 2004-10-01

COMPLETED

Common interventions

PlaceboDRUG3ABT-639DRUG1BVT.115959DRUG1donepezilDRUG1donepezil 2.5 mg and duloxetine 30mgDRUG1duloxetineDRUG1gabapentinDRUG1Identification of genetic causes of diabetic neuropathic painGENETIC1intermittent pneumatic compression +pregabalin groupDEVICE1pregabalinDRUG1pregabalin groupOTHER1

Leading sponsors

AbbVie (prior sponsor, Abbott)1Busra Gunes1Swedish Orphan Biovitrum1University of Dundee1Wake Forest University1

Trial status mix

COMPLETED4

TERMINATED1

Phase mix

PHASE22

NA1

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.